Article Details
Retrieved on: 2025-03-24 16:01:29
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
EVM14, EVM16 and in-vivo CAR-T programs are the core pillars of Everest's oncology and autoimmune disease innovation strategy. SHANGHAI, China I ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here